Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Study Phase : Discovery
Sponsor : Cumulus Oncology
Deal Size : Undisclosed
Deal Type : Collaboration
Details : Under the collaboration, the companies will focus on the discovery and development of small molecules targeting an undisclosed and novel cancer-focused G protein-coupled receptor (GPCR).
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
July 17, 2023
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Highest Development Status : Discovery
Sponsor : Cumulus Oncology
Deal Size : Undisclosed
Deal Type : Collaboration
Reset All
